Skip to main content
Guidance

Severe Disability Group test: information for clinicians

Guidance for clinicians regarding the information they are required to provide on a customer's condition, as part of the Severe Disability Group test.

Updates to this page

From:
Department for Work and Pensions
Published:
19 February 2024
Last updated:
17 April 2024
Show all updates

  1. Under 'Cardiorespiratory conditions', changed the limiting symptoms for pulmonary arterial hypertension on optimal medical therapy from 'NYHA 3 to 4' to 'NYHA IV'.

  2. Under 'Examples of conditions that are likely to meet the criteria (for illustrative purposes only and not to be regarded as a comprehensive list' - the ' - heart failure.. limiting symptoms' have changed from 'NYHA 3 to 4' to 'NYHA 4'. This is due to a change in criteria for heart failure patients.

  3. The email address has been removed and replaced with 'return to the inbox provided on the referral form' .

  4. 'Examples of social and everyday functioning that might be affected' and 'Examples of conditions that are likely to meet the criteria' sections have been added to the HTML attachment.

  5. First published.

This publication was withdrawn on

This page has been withdrawn as it contained policy developed by the previous government. The current government’s policy is set out in the: Pathways to Work: Reforming Benefits and Support to Get Britain Working Green Paper - GOV.UK

Documents

Severe Disability Group test: information for clinicians

HTML

Details

The Department for Work and Pensions is currently testing a white paper initiative called ‘Severe Disability Group’. This looks to reduce the burden on customers with life long disabling conditions to fill in PIP application forms and attend assessments. This is guidance for clinicians on the information they need to provide about a customer’s condition to identify if there is enough information to change a customer’s award.

Sign up for emails or print this page

Related content